US M&A and equity raisings

3,392 deals since January 2025, with sources and adviser credits where available · as at 20 Nov 2026 · Venture rounds

Deals dated after 30 September 2026 are still being collected.

Deal size
Custom range

93 deals · US$26bndisclosed · Healthcare · Clear

Columns
US M&A deals and equity raisings
Date Target Vendor Acquirer Type Status Value US$m Sector Advisers
Sep 2026 ADARx Pharmaceuticals ––IPOAnnounced446.3Biotech+1 Cooley (issuer)J.P. Morgan (lead manager)Morgan Stanley (lead manager)TD Securities (lead manager)UBS (lead manager)LifeSci Capital (lead manager)Latham & Watkins (lead manager)
Sep 2026 ADARx Pharmaceuticals ––PlacementAnnounced89.0Biotech+1 J.P. Morgan (lead manager)Morgan Stanley (lead manager)TD Securities (lead manager)UBS (lead manager)LifeSci Capital (lead manager)
Sep 2026 Marea Therapeutics ––PlacementAnnounced225.0Biotech Cooley (lead manager)
Sep 2026 North Immunology ––PlacementAnnounced180.0Biotech Cooley (lead manager)Jefferies (lead manager)Leerink Partners (lead manager)BofA Securities (lead manager)UBS (lead manager)
Sep 2026 Beta Bionics ––Follow-on offeringAnnounced172.5Medtech Piper Sandler (lead manager)
Sep 2026 Tenon Medical ––Registered direct or warrant-inducement placementCompleted2.9Medtech WallachBeth Capital (issuer)
Sep 2026 Electra Therapeutics ––IPOAnnounced350.0Biotech+1 Cooley (issuer)Jefferies (lead manager)TD Securities (lead manager)Evercore (lead manager)Cantor Fitzgerald (lead manager)Latham & Watkins (lead manager)
Sep 2026 Pyxis Oncology ––Follow-on offeringAnnounced110.0Biotech+1 Latham & Watkins (lead manager)
Aug 2026 Amylyx Pharmaceuticals ––Follow-on offeringAnnounced575.2Biotech+1 Goodwin (issuer)Leerink Partners (lead manager)Morgan Stanley (lead manager)Guggenheim Securities (lead manager)LifeSci Capital (lead manager)
Aug 2026 AbCellera Biologics ––Follow-on offeringCompleted200.0Biotech+1 Goodwin (issuer)
Aug 2026 Ambros Therapeutics ––PlacementAnnounced150.0Biotech+1 Cooley (issuer)
Aug 2026 Werewolf Therapeutics ––PlacementAnnounced150.0Biotech+2 Leerink Partners (lead manager)Piper Sandler (lead manager)Cantor Fitzgerald (lead manager)Wells Fargo Securities (lead manager)LifeSci Capital (lead manager)Latham & Watkins (lead manager)
Aug 2026 Silence Therapeutics ––PlacementCompleted201.0Biotech+1 Goodwin (lead manager)Jefferies (lead manager)Morgan Stanley (lead manager)Cantor Fitzgerald (lead manager)William Blair (lead manager)
Aug 2026 Slate Medicines ––PlacementAnnounced245.0Biotech+1 Cooley (issuer)
Aug 2026 Skye Bioscience ––PlacementAnnounced68.0Biotech+1 Leerink Partners (lead manager)MTS Health Partners (lead manager)Mintz (lead manager)
Aug 2026 Janus Living ––Follow-on offeringCompleted464.0REITs+1 Latham & Watkins (issuer)Ballard Spahr (issuer)BofA Securities (lead manager)J.P. Morgan (lead manager)Wells Fargo Securities (lead manager)BNP Paribas (lead manager)Crédit Agricole CIB (lead manager)Mizuho Securities (lead manager)Morgan Stanley (lead manager)RBC Capital Markets (lead manager)Scotiabank (lead manager)Truist Securities (lead manager)BTIG (lead manager)Citizens JMP (lead manager)Huntington Securities (lead manager)M&T Securities (lead manager)Samuel A. Ramirez & Company (lead manager)Raymond James (lead manager)Roberts & Ryan (lead manager)SMBC Nikko Securities (lead manager)Sidley Austin (lead manager)
Aug 2026 Braveheart Bio ––IPOListed382.5Biotech+2 Goodwin (issuer)Goldman Sachs (lead manager)Jefferies (lead manager)TD Securities (lead manager)Stifel (lead manager)Cantor Fitzgerald (lead manager)Covington & Burling (lead manager)
Aug 2026 Ensysce Biosciences ––PlacementAnnounced43.0Biotech+1 Cantor Fitzgerald (lead manager)UBS (lead manager)Mintz (lead manager)
Aug 2026 Attovia Therapeutics ––IPOListed289.0Biotech+1 Fenwick & West (issuer)Morgan Stanley (lead manager)Leerink Partners (lead manager)Citi (lead manager)RBC Capital Markets (lead manager)LifeSci Capital (lead manager)Cooley (lead manager)
Aug 2026 BlossomHill Therapeutics ––IPOListed150.0Biotech+2 Cooley (issuer)J.P. Morgan (lead manager)Leerink Partners (lead manager)Guggenheim Securities (lead manager)LifeSci Capital (lead manager)H.C. Wainwright & Co. (lead manager)Latham & Watkins (lead manager)
Aug 2026 Latigo Biotherapeutics ––IPOListed345.6Biotech+2 Cooley (issuer)Goldman Sachs (lead manager)Jefferies (lead manager)Leerink Partners (lead manager)Guggenheim Securities (lead manager)Latham & Watkins (lead manager)
Jul 2026 Apnimed ––IPOListed192.0Biotech+1 Goodwin (issuer)BofA Securities (lead manager)Evercore (lead manager)Cantor Fitzgerald (lead manager)LifeSci Capital (lead manager)Cleary Gottlieb Steen & Hamilton (lead manager)
Jul 2026 Caldera Therapeutics ––PlacementAnnounced278.0Biotech+1 Jefferies (lead manager)TD Securities (lead manager)Guggenheim Securities (lead manager)UBS (lead manager)LifeSci Capital (lead manager)Cooley (lead manager)
Jul 2026 Inovio Pharmaceuticals ––Follow-on offeringCompleted–Biotech+1 Piper Sandler (issuer)
Jul 2026 Processa Pharmaceuticals ––PlacementAnnounced200.0Biotech+1 Leerink Partners (lead manager)Evercore (lead manager)UBS (lead manager)Wells Fargo Securities (lead manager)Mintz (lead manager)
Jul 2026 Research Alliance Corporation III ––PlacementAnnounced100.0Biotech+2 Leerink Partners (lead manager)UBS (lead manager)Wells Fargo Securities (lead manager)LifeSci Capital (lead manager)Kirkland & Ellis (lead manager)
Jul 2026 Codexis ––Follow-on offeringCompleted–Biotech+1 Piper Sandler (lead manager)
Jul 2026 Scribe Therapeutics ––IPOListed128.7Biotech+1 Fenwick & West (issuer)Leerink Partners (lead manager)Goldman Sachs (lead manager)Guggenheim Securities (lead manager)Wells Fargo Securities (lead manager)Latham & Watkins (lead manager)
Jul 2026 Jasper Therapeutics ––PlacementAnnounced132.0Biotech+1 Piper Sandler (lead manager)LifeSci Capital (lead manager)
Jul 2026 Avere Therapeutics ––PlacementAnnounced320.0Biotech+1 Sullivan & CromwellGibson Dunn (issuer)Cooley (lead manager)Jefferies (lead manager)Wedbush Securities (lead manager)
Jul 2026 Enlitic ––PlacementCompleted10.5Medtech Barrenjoey (lead manager)
Jul 2026 BridgeBio Pharma ––PlacementAnnounced1,000.0Biotech+1 EvercoreSullivan & CromwellMintzGibson DunnLatham & Watkins (issuer)
Jun 2026 Tenon Medical ––Follow-on offeringAnnounced4.2Medtech Sichenzia Ross Ference Carmel (issuer)WallachBeth Capital (lead manager)Sheppard, Mullin, Richter & Hampton (lead manager)
Jun 2026 JATT II Acquisition Corp ––PlacementAnnounced225.0Biotech+1 Guggenheim Securities (lead manager)Cantor Fitzgerald (lead manager)LifeSci Capital (lead manager)Davis Polk (lead manager)
Jun 2026 Remix Therapeutics ––PlacementPending100.0Biotech+2 Goldman Sachs (lead manager)Jefferies (lead manager)Evercore (lead manager)Cooley (lead manager)
Jun 2026 Kardigan ––IPOListed400.0Biotech+2 Goodwin (issuer)J.P. Morgan (lead manager)Jefferies (lead manager)Leerink Partners (lead manager)TD Securities (lead manager)Latham & Watkins (lead manager)
Jun 2026 Enhanced Group ––PlacementPending50.0Healthcare Services+2 Cooley (issuer)Cantor Fitzgerald (lead manager)DLA Piper (lead manager)
Jun 2026 Parabilis Medicines ––PlacementCompleted75.0Biotech+1 Goodwin (issuer)
Jun 2026 Adial Pharmaceuticals ––PlacementPending32.0Biotech+1 TD Securities (issuer)Lucid Capital Markets (lead manager)
Jun 2026 Parabilis Medicines ––IPOListed670.0Biotech+2 Goodwin (issuer)Leerink Partners (lead manager)BofA Securities (lead manager)Evercore (lead manager)Guggenheim Securities (lead manager)LifeSci Capital (lead manager)Covington & Burling (lead manager)
Jun 2026 EBR Systems ––Entitlement offerCompleted103.3Medtech Johnson Winter Slattery (issuer)Canaccord Genuity (lead manager)E&P Capital (lead manager)Morgans (lead manager)
Jun 2026 Janus Living ––Follow-on offeringAnnounced625.0REITs+1 Latham & Watkins (issuer)Ballard Spahr (issuer)BofA Securities (lead manager)J.P. Morgan (lead manager)RBC Capital Markets (lead manager)Wells Fargo Securities (lead manager)Goldman Sachs (lead manager)Morgan Stanley (lead manager)Barclays (lead manager)Jefferies (lead manager)KeyBanc Capital Markets (lead manager)TD Securities (lead manager)Crédit Agricole CIB (lead manager)Regions Securities (lead manager)Santander (lead manager)Capital One Securities (lead manager)Sidley Austin (lead manager)
Jun 2026 Avenzo Therapeutics ––PlacementPending215.0Biotech+2 Leerink Partners (lead manager)Goldman Sachs (lead manager)Piper Sandler (lead manager)Guggenheim Securities (lead manager)Mintz (lead manager)
May 2026 Medline Blackstone Funds–Follow-on offeringAnnounced2,684.5Healthcare+2 Simpson Thacher & Bartlett (issuer)Goldman Sachs (lead manager)Morgan Stanley (lead manager)BofA Securities (lead manager)J.P. Morgan (lead manager)Barclays (lead manager)Citi (lead manager)Deutsche Bank (lead manager)Jefferies (lead manager)UBS (lead manager)Evercore (lead manager)BMO Capital Markets (lead manager)BNP Paribas (lead manager)MUFG (lead manager)RBC Capital Markets (lead manager)Santander (lead manager)Societe Generale (lead manager)TD Securities (lead manager)Wells Fargo Securities (lead manager)Leerink Partners (lead manager)Macquarie Capital (lead manager)Mizuho Securities (lead manager)Piper Sandler (lead manager)Truist Securities (lead manager)William Blair (lead manager)Blackstone Securities Partners (lead manager)TCG Capital Markets (lead manager)Baird (lead manager)Rothschild & Co (lead manager)Stifel (lead manager)BTIG (lead manager)ING (lead manager)IMI Intesa Sanpaolo (lead manager)NCMG (lead manager)Perella Weinberg Partners (lead manager)Academy Securities (lead manager)AmeriVet Securities (lead manager)Blaylock Van (lead manager)C.L. King & Associates (lead manager)Drexel Hamilton (lead manager)Loop Capital Markets (lead manager)Mischler Financial Group (lead manager)R. Seelaus & Co. (lead manager)Samuel A. Ramirez & Company (lead manager)Siebert Williams Shank & Co. (lead manager)Tigress Financial Partners (lead manager)Nomura (lead manager)WR Securities (lead manager)Latham & Watkins (lead manager)
May 2026 Mentari Therapeutics ––PlacementAnnounced290.0Biotech+1 Gibson Dunn (issuer)Cooley (lead manager)Jefferies (lead manager)TD Securities (lead manager)Stifel (lead manager)Guggenheim Securities (lead manager)Wedbush Securities (lead manager)
May 2026 Optimi Health Corp. ––Follow-on offeringAnnounced15.0Biotech+2 Norton Rose Fulbright (issuer)Joseph Gunnar & Co. (lead manager)Cozen O'Connor (lead manager)
May 2026 Quince Therapeutics ––PlacementAnnounced115.0Biotech+2 EvercoreCantor FitzgeraldLifeSci Capital (lead manager)Gibson Dunn (lead manager)
May 2026 GMR Solutions ––PlacementAnnounced500.0Healthcare Services Latham & Watkins
May 2026 GMR Solutions ––IPOAnnounced478.7Healthcare Services Simpson Thacher & Bartlett (issuer)J.P. Morgan (lead manager)KKR Capital Markets (lead manager)BofA Securities (lead manager)Barclays (lead manager)Goldman Sachs (lead manager)Evercore (lead manager)Citi (lead manager)Morgan Stanley (lead manager)UBS (lead manager)Capital One Securities (lead manager)Regions Securities (lead manager)Loop Capital Markets (lead manager)Latham & Watkins (lead manager)
May 2026 Conexeu Sciences ––Direct listingAnnounced–Life Sciences H.C. Wainwright & Co. (issuer)

Deals come from SEC filings (merger proxies, tender offers, 8-K announcements and IPO prospectuses), the deal pages and transaction lists of law firms and banks, companies' press releases and the press. How the data is built